Groundbreaking Partnership: NHS Awards First Service Contract to Kneu Health

11 March 2024 — The National Health Service (NHS) has officially awarded its first service contract to Kneu Health, a HealthTech spinout from the University of Oxford, marking a significant step forward in the integration of cutting-edge technology into the nation's healthcare system for people with Parkinson's Disease.

The contract sees the implementation of Kneu Health's state-of-the-art technology in East Suffolk and North Essex NHS Foundation Trust (ESNEFT), with the first patients starting to use the technology in December 2023. Patients, clinicians and the health system are reporting positive experience and outcomes as highlighted in today's press release by ESNEFT.

Amidst an era of rapid technological advancements, ESNEFT has chosen to collaborate with Kneu Health to improve patient outcomes and enhance efficiency within the healthcare system.

Dr Kinan Muhammed, Kneu Health's Chief Medical Officer said: "We are delighted to partner with ESNEFT on this novel and transformative initiative. This has the potential to reshape the way Neurology care is delivered within the NHS, ultimately benefiting both patients and healthcare professionals."

"It is wonderful for people with Parkinson's Disease to be benefiting from this new technology. I have been involved in the development of the Kneu Health platform and I believe that it will transform the management of this condition for people like me," said Sally Bromley, Kneu Health's expert patient advisor.

Key features of the partnership include:

Implementation of Cutting-Edge Technology: Kneu Health's platform is integrated into ESNEFT's outpatient facilities to optimise patient care and streamline operational processes for people with Parkinson's Disease.

Data Security and Compliance: Stringent measures are in place to safeguard patient data and ensure compliance with all relevant healthcare regulations. The Kneu Health Platform is a class I software as a medical device, MHRA-registered, UKCA-marked, and DTAC compliant. The partnership prioritises the privacy and security of patient information.

Engagement with people with Parkinson's Disease: Individuals living with Parkinson's are closely involved in the design and implementation of the technology and service.

As the collaboration progresses, both ESNEFT and Kneu Health anticipate positive outcomes that will ultimately contribute to an enhanced healthcare experience for people living with Parkinson's Disease and a more efficient healthcare system for providers. The partnership signifies an important step in the ongoing efforts to leverage technology for the betterment of public health in the United Kingdom.

About Kneu Health

Kneu Health is pioneering a new model of precision neurology for Parkinson's and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson's care — the Oxford Parkinson's Disease Centre Discovery Cohort — Kneu's smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Kneu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring.